Measure ID: MIPS 168|Cardiac Surgery|2026 Performance Year

2026 MIPS Measure #168: Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration

Percentage of patients aged 18 years and older undergoing isolated coronary artery bypass graft (CABG) surgery who require a return to the operating room (OR) for mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native vessel, graft or both), valve dysfunction, aortic reintervention or other cardiac reason during the current hospitalization.

Outcome – High PriorityCardiac SurgeryPatient Safety
Measure ID:MIPS 168 (Quality ID 168)
Collection:MIPS CQM
Topped Out:No
View CMS Spec ↗

Measure Specification

Eligible Population
All patients aged 18 years and older on date of surgery
ANDPatient procedure during the performance period
ORPatient procedure during the performance period
ANDPatient procedure during the performance period
Exclusions

None

Numerator
Patients undergoing isolated CABG surgery who require a return to the OR for mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native vessel, graft or both), valve dysfunction, aortic reintervention or other cardiac reason during the current hospitalization.
Reporting Codes

Performance Met:

G8577Re-exploration required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native vessel, graft or both), valve dysfunction, aortic reintervention, or other cardiac reason

Performance Not Met:

G8578Re-exploration not required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native vessel, graft or both), valve dysfunction, aortic reintervention, or other cardiac reason
VBCA Insights

Why This Measure Matters

Reoperation after bypass surgery for bleeding, clotting issues, or valve problems is a major setback that extends hospitalization and raises complications. This outcome measure tracks how many of your bypass patients avoid returning to the OR. Lower rates reflect sound surgical technique, proper anticoagulation protocols, and vigilant post-operative monitoring. Building a culture of early recognition and conservative management of post-op bleeding can significantly improve this metric.

VBCA is a CMS-approved Qualified Clinical Data Registry (QCDR) that submits MIPS Measure 168 to the Quality Payment Program (QPP). Practices can report this measure as a MIPS Clinical Quality Measure (CQM) or through qualified registry submission.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.

Specialty Measure Sets

Related Measures

Patient Safety
MIPS 130: Documentation of Current Medications in the Medical RecordMIPS 145: Radiology: Exposure Dose Indices Reported for Procedures Using FluoroscopyMIPS 155: Falls: Plan of CareMIPS 164: Coronary Artery Bypass Graft (CABG): Prolonged IntubationMIPS 181: Elder Maltreatment Screen and Follow-Up PlanMIPS 259: Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-RupturedMIPS 275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status BeforeMIPS 286: Dementia: Safety Concern Screening and Follow-Up for Patients with DementiaMIPS 351: Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular RiskMIPS 354: Anastomotic Leak InterventionMIPS 355: Unplanned Reoperation within the 30-Day Postoperative PeriodMIPS 357: Surgical Site Infection (SSI)MIPS 374: Closing the Referral Loop: Receipt of Specialist ReportMIPS 384: Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the OperatingMIPS 385: Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity ImprovementMIPS 392: Cardiac Tamponade and/or Pericardiocentesis Following Atrial FibrillationMIPS 393: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation,MIPS 413: Door to Puncture Time for Endovascular Stroke TreatmentMIPS 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ ProlapseMIPS 432: Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any PelvicMIPS 513: Patient Reported Falls and Plan of Care

Clinical Rationale

In 2000, CABG surgery was performed on more than 350,000 patients at a cost of close to $20 billion. Re-exploration after surgery is a serious complication that impacts length of stay, efficient use of resources, and increases risk for additional complications and death. As one of several major complications of cardiac surgery, repeat surgery is particularly worrisome for consumers and is an inefficient use of resources.

Clinical Recommendations

Re-exploration after surgery is a serious complication that impacts length of stay, efficient use of resources, and increases risk for additional complications and death. This measure is currently in use by approximately 65% of providers in the United States who perform cardiac surgery and report data to the Society of Thoracic Surgeons (STS) National Database.

Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this procedure measure is submitted each time a procedure is performed during the performance period. This is an inverse measure which means a lower calculated performance rate for this measure indicates better clinical care or control.

The “Performance Not Met” numerator option for this measure is the representation of the better clinical quality or control. Submitting that numerator option will produce a performance rate that trends closer to 0%, as quality increases. For inverse measures, a rate of 100% means all of the denominator eligible patients did not receive the appropriate care or were not in proper control.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →Talk to Us

© This measure is owned by The Society of Thoracic Surgeons (STS). Copyright 2025.